---
format: "aidr-story-markdown/v1"
id: "6b1ddc5d928430d89b73f2725874c9efad89b61ed72f00d49f7df2317bd57c94"
canonical_url: "https://aidr.today/6b1ddc5d?lang=en"
title: "Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs (Xavier Martinez/Wall Street Journal)"
lang: "en"
requested_lang: "en"
available_langs: ["en","vi"]
translation_fallback: null
fallback_fields: []
published_at: "2026-11-04T04:20:01.000Z"
category: "Regulation"
topics: ["regulation"]
source_urls: ["https://www.techmeme.com/261103/p48"]
summary: "Pharmaceutical leaders remain skeptical of claims that AI could cure most diseases within a decade, and the US FDA has not yet cleared any AI-designed biotech drugs, citing biology as the primary obstacle."
---

# Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI\-designed biotech drugs \(Xavier Martinez/Wall Street Journal\)

> [Open the canonical story](<https://aidr.today/6b1ddc5d?lang=en>)

**Published:** 2026-11-04T04:20:01.000Z
**Category:** Regulation
**Topics:** regulation

## Summary

Pharmaceutical leaders remain skeptical of claims that AI could cure most diseases within a decade, and the US FDA has not yet cleared any AI\-designed biotech drugs, citing biology as the primary obstacle\.

## Sources

- [Story source](<https://www.techmeme.com/261103/p48>)